(ADMA) - Analyzing ADMA Biologics's Short Interest
Portfolio Pulse from Benzinga Insights
ADMA Biologics (NYSE:ADMA) has seen a 37.52% increase in its short percent of float, now at 7.55%. This indicates a rise in bearish sentiment, although it remains below the peer group average of 15.05%. Short interest can signal market sentiment and potential price movements.
October 22, 2024 | 7:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ADMA Biologics has experienced a significant increase in short interest, rising by 37.52% to 7.55% of its float. This suggests a growing bearish sentiment among investors, although its short interest remains below the peer average of 15.05%.
The increase in short interest suggests that investors are becoming more bearish on ADMA Biologics, which could lead to downward pressure on the stock price. However, the short interest is still below the peer average, which may mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100